Amphastar Pharmaceuticals
AMPH· Manufacturing· Fiscal year ends in December
Jack Yongfeng Zhang is the CEO of Amphastar Pharmaceuticals and was paid $7.5M in FY2022 (Dec), up 15%.
Executives5
See all- 1Jack Yongfeng ZhangChief Executive Officer, President, Chief Scientific Officer and DirectorFY2022
- 2Mary Ziping LuoChief Operating Officer, Chief Scientist and ChairmanFY2022
- 3William J. PetersChief Financial Officer, Executive Vice President of Finance, Treasurer, President of International Medication Systems, Limited, and DirectorFY2022
- 4Rong ZhouSenior Executive Vice President of Production and President of Amphastar Nanjing Pharmaceuticals, Co., LtdFY2022
- 5Jacob LiawatidewiExecutive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S.FY2022
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAmphastar Pharmaceuticals paid its 5 named executives $17.3M in total in FY2022 (Dec). CEO Jack Yongfeng Zhang was paid $7.5M of that.
| Name | ||
|---|---|---|
| Jack Yongfeng ZhangChief Executive Officer, President, Chief Scientific Officer and Director | ||
| Mary Ziping LuoChief Operating Officer, Chief Scientist and Chairman | ||
| William J. PetersChief Financial Officer, Executive Vice President of Finance, Treasurer, President of International Medication Systems, Limited, and Director | ||
| Rong ZhouSenior Executive Vice President of Production and President of Amphastar Nanjing Pharmaceuticals, Co., Ltd | ||
| Jacob LiawatidewiExecutive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S. |
of each named executive, from the Summary Compensation Table of each proxy.
Peers16
See allThe FY2025 (Dec) proxy of Amphastar Pharmaceuticals names 16 peer companies for pay. Among Amphastar Pharmaceuticals and these peers, CEO pay was 7th highest of 10 and total shareholder return was 7th highest of 10.
7th highest of 10in Amphastar Pharmaceuticals and its pay peers, FY2025 (Dec) by CEO pay:
7th highest of 10in Amphastar Pharmaceuticals and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board5
See all- Mary Ziping LuoChair · 29 yr on the boardNot independent—Paid as an executive
- Richard PrinsLead independent director · 23 yr on the boardIndependentAudit, Compensation—Paid as an executive
- Gayle DeflinDirector · 4 yr on the boardIndependentAudit (Chair)—Paid as an executive
- Jacob LiawatidewiDirector · 3 yr on the boardNot independent—Paid as an executive
- William J. PetersDirector · 3 yr on the boardNot independent—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 13, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 14, 2025 | FY2024 |
| Annual report | 10-K | Mar 3, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 12, 2024 | FY2023 |
| Annual report | 10-K | Feb 29, 2024 | FY2023 |